Novateor Research Laboratories Ltd - 542771 - Statement Of Investor Complaints For The Quarter Ended March 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Navdeep MehtaDesignation :- Managing Director / Whole Time Director Novateor Research Laboratories Ltd - 542771 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 Novateor Research Laboratories Ltd - 542771 - Closure of Trading Window
pursuit to Code of Conduct for prevention of Insider Trading adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, the Trading Window for trading in the Securities of the Company will remain closed with effect from April 1, 2022 for all the Directors, Designated Persons and their immediate relative(s). The Trading Window will be opened 48 hours after the announcement of the Financial Results for the half year and year ended on March 31, 2022. Novateor Research Laboratories Ltd - 542771 - Intimation Pursuant To Part A Of Schedule III Of SEBI (LODR) Regulations, 2015
Pursuant to Regulation 30 read with Para B of Part A of Schedule III of the SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, Intimation of launch of new product. Novateor Research Laboratories Ltd - 542771 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Navdeep MehtaDesignation :- Managing Director / Whole Time Director Novateor Research Laboratories Ltd - 542771 - Board Meeting Outcome for Outcome Of Board Meeting
Pursuat to Regulation 30, 33 and any other Regulation of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 that a meeting of the Board of Directors of the Company was held on Sunday, 14% November, 2021 but discussion was pending due to constrain of time. So; Board Meeting was held today i.e. Monday, November 15, 2021 at Registered office of the company, in that meeting the Board has considered and approved the Un-audited financial results of the Company for the half year ended on 30th September, 2021 with Limited Review Report of the Statuatory Auditor. Novateor Research Laboratories Ltd - 542771 - Unaudited Financial Results For The Half Year Ended On 30Th September, 2021
Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended ("SEBI Listing Regulations"), we wish to inform you that the Board of Directors of the company at their meeting , inter alia consider and approve Unaudited half yearly financial results along with Limited Review Report for Half year ending on September 30, 2021. Novateor Research Laboratories Ltd - 542771 - Board Meeting Intimation for Intimation Of Board Meeting
Novateor Research Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2021 ,inter alia, to consider and approve the Unaudited financial results of the company for the half year ended September 30, 2021 Novateor Research Laboratories Ltd - 542771 - Shareholding for the Period Ended September 30, 2021
Novateor Research Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here Novateor Research Laboratories Ltd - 542771 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended on 30th September, 2021